STTK

1.15

10.58% 0.11

Handel nachbörslich: 1.18 0.03 +2.61%

Shattuck Labs Inc (STTK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.04

Offen:

$1.02

24-Stunden-Volumen:

424.98K

Relative Volume:

0.66

Marktkapitalisierung:

$54.90M

Einnahmen:

$2.72M

Nettoeinkommen (Verlust:

$-85.08M

KGV:

-0.53

EPS:

-2.17

Netto-Cashflow:

$-70.93M

1W Leistung:

+0.88%

1M Leistung:

+3.60%

6M Leistung:

-72.39%

1J Leistung:

-82.17%

1-Tages-Spanne:

$1.02

$1.16

1-Wochen-Bereich:

$1.02

$1.19

52-Wochen-Spanne:

$0.94

$11.76

Shattuck Labs Inc Stock (STTK) Company Profile

Firmenname

Shattuck Labs Inc

Sektor

Healthcare (1176)

Branche

Biotechnology (673)

Telefon

512-900-4690

Adresse

500 W. 5TH STREET, AUSTIN

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

STTK's Discussions on Twitter

Vergleichen Sie STTK mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
STTK Shattuck Labs Inc	1.15	54.90M	2.72M	-85.08M	-70.93M	-1.93
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-10-02	Herabstufung	Citigroup	Buy → Neutral
2024-10-02	Herabstufung	Needham	Buy → Hold
2024-10-01	Herabstufung	H.C. Wainwright	Buy → Neutral
2024-06-17	Herabstufung	BTIG Research	Buy → Neutral
2022-08-31	Eingeleitet	BTIG Research	Buy
2022-06-01	Eingeleitet	Citigroup	Buy
2022-05-02	Eingeleitet	H.C. Wainwright	Buy
2021-04-14	Eingeleitet	Berenberg	Buy
2021-01-11	Eingeleitet	Evercore ISI	Outperform
2020-11-03	Eingeleitet	Citigroup	Buy
2020-11-03	Eingeleitet	Cowen	Outperform
2020-11-03	Eingeleitet	Needham	Buy

Alle ansehen

Shattuck Labs Inc Aktie (STTK) Neueste Nachrichten

Dec 11, 2024

STTK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online

Dec 11, 2024

MetLife Investment Management LLC Raises Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World

Dec 11, 2024

Dec 10, 2024

STTK LAWSUIT ALERT: Levi & Korsinsky Notifies Shattuck Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Marketscreener.com

Dec 10, 2024

Dec 07, 2024

Shattuck Labs, Inc. (NASDAQ:STTK) Director Buys $166,713.75 in Stock - MarketBeat

Dec 07, 2024

Dec 06, 2024

Redmile Group, LLC Reduces Stake in Shattuck Labs Inc - GuruFocus.com

Dec 06, 2024

Shattuck Labs sees $166,713 in stock sales by Redmile Group - Investing.com

Dec 06, 2024

Nov 26, 2024

GSA Capital Partners LLP Invests $121,000 in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World

Nov 26, 2024

Nov 25, 2024

Shattuck Labs to Present at Piper Sandler and Evercore Healthcare Conferences | STTK Stock News - StockTitan

Nov 25, 2024

Nov 24, 2024

Shattuck Labs Falls To US$1.01, But Insiders Sold At Lower Price - Simply Wall St

Nov 24, 2024

Nov 22, 2024

Shattuck Labs stock plunges to 52-week low at $1.06 By Investing.com - Investing.com Canada

Nov 22, 2024

Nov 21, 2024

Shattuck Labs stock plunges to 52-week low at $1.06 - Investing.com India

Nov 21, 2024

Nov 20, 2024

Citigroup Downgrades Shattuck Labs (STTK) - MSN

Nov 20, 2024

Nov 19, 2024

Shattuck Labs’ (STTK) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Nov 19, 2024

Nov 18, 2024

STTK (Shattuck Labs) Degree of Operating Leverage : -0.01 (As of Jun. 2024) - GuruFocus.com

Nov 15, 2024

Shattuck Labs' (STTK) "Neutral" Rating Reiterated at HC Wainwright - MarketBeat

Nov 15, 2024

Shattuck Labs sees cash runway into 2027 - Yahoo Finance

Nov 15, 2024

Nov 14, 2024